fbpx
August 30, 2022

Ublituximab Bests Teriflunomide for MS in Two Phase 3 Trials Ublituximab Bests Teriflunomide for MS in Two Phase 3 Trials

Patients with relapsing multiple sclerosis (MS) treated with intravenous ublituximab had fewer relapses and brain lesions compared with those treated with oral teriflunomide, although both therapies […]
August 25, 2022

Remote Ischemic Conditioning Neuroprotective After Stroke? Remote Ischemic Conditioning Neuroprotective After Stroke?

Remote ischemic conditioning (RIC), a process that involves repeated occlusion/release cycles on bilateral upper limb arteries, is superior to usual care in optimizing neurologic function for […]
August 24, 2022

Health Spending vs ‘Latitude Hypothesis’ for Higher MS Prevalence Health Spending vs ‘Latitude Hypothesis’ for Higher MS Prevalence

How much a country spends on healthcare may have greater bearing on global variations in multiple sclerosis (MS) prevalence than distance from the equator, suggests new […]
August 24, 2022

AI Uses Nocturnal Breathing Patterns to Detect Parkinson’s AI Uses Nocturnal Breathing Patterns to Detect Parkinson’s

An artificial intelligence (AI) model can detect Parkinson’s disease (PD), assess its severity, and track its progression using nocturnal breathing signals, new research suggests. In a […]
August 24, 2022

Spinal Injury Repair ‘Negligence’ Ends in $15.5 Million Verdict Spinal Injury Repair ‘Negligence’ Ends in $15.5 Million Verdict

A Florida jury has determined that a neurosurgeon was largely responsible for a man’s post-accident paralysis and has awarded the patient and his wife $15.5 million […]
August 23, 2022

Noninvasive Brain Stimulation May Boost Memory for 4 Weeks Noninvasive Brain Stimulation May Boost Memory for 4 Weeks

Transcranial alternating current stimulation (tACS) for 20 minutes over 4 consecutive days can improve both short- and long-term memory for at least 1 month in older […]
August 23, 2022

FDA Clears New Neurostimulation System for Chronic Pain FDA Clears New Neurostimulation System for Chronic Pain

The US Food and Drug Administration (FDA) has approved Abbott Laboratories’ new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy for the treatment of […]
August 23, 2022

Novel Internet Intervention Improves Tourette Tic Severity Novel Internet Intervention Improves Tourette Tic Severity

A novel internet-delivered, therapist-supported version of exposure and response prevention (ERP) therapy can yield improvements in tic severity in Tourette syndrome (TS) or chronic tic disorder […]
August 22, 2022

Incomplete Recovery Common 6 Months After Mild TBI Incomplete Recovery Common 6 Months After Mild TBI

More than half of patients with mild traumatic brain injury (TBI) and a negative head CT scan have not recovered completely 6 months after sustaining their […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0